Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
2025 Standout
Pancreatic cancer
2025 Standout
Works of Simon Tian being referenced
Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2–5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study
2019
An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2–5 years (KLIMB)
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Simon Tian | 944 | 87 | 89 | 90 | 30 | 998 | |
| Stefanie J. Millar | 793 | 61 | 47 | 45 | 29 | 881 | |
| Donatello Salvatore | 733 | 24 | 44 | 58 | 56 | 851 | |
| Edward F. McKone | 1009 | 44 | 84 | 33 | 40 | 1.3k | |
| Sheila G. McKenzie | 872 | 41 | 46 | 51 | 14 | 1.1k | |
| William T. Harris | 959 | 65 | 27 | 77 | 41 | 1.2k | |
| Nico Derichs | 1213 | 36 | 21 | 56 | 32 | 1.4k | |
| Kathleen Naughton | 796 | 47 | 16 | 64 | 17 | 980 | |
| Vincent Gulmans | 695 | 30 | 16 | 93 | 27 | 909 | |
| Vicky A. LeGrys | 1098 | 17 | 16 | 54 | 30 | 1.4k | |
| Y. Yahav | 726 | 41 | 10 | 90 | 32 | 980 |
All Works
Loading papers...